Abobotulinumtoxina
Abobotulinumtoxina is a pharmaceutical drug with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A
Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin
Dysport Dose-Ranging Treatment of Platysmal Bands
Clinical Trials (11)
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A
Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin
Dysport Dose-Ranging Treatment of Platysmal Bands
Subject Satisfaction With AbobutulinumtoxinA Treatment
Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
The Treatment of Shoulder Pain in Hemiplegic Spastic Patients With Botulinum Toxin A
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
Abobotulinumtoxina Efficacy in Post-Traumatic Headache
Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11